On-Demand Webinar: A High Throughput Approach to Developing T- Cell Immunotherapies
T cell immunotherapy is a rapidly growing personalized treatment that expands unmodified cellular products ex vivo for re-infusion into patients. This webinar will discuss the promise and pitfalls associated with developing individualized antigen-specific T cell therapy products for clinical use.
Register to watch on demand
Christopher Lazarski, Ph.DStaff Scientist III Children’s National Medical Center (CNMC)
Dr. Lazarski is an immunologist with extensive training in T cell responses in animal models, vaccines, and cell therapy products. His past experience in academia and industry involved investigating the signals required for CD8+ and CD4+ effector function in models of infection and immunity, along with the pathways for processing and presentation of vaccine antigens to T cells. He has also developed novel measures for flow cytometric based analysis of the frequency of lymphocyte subsets and activation. As a Research Scientist at GenVec, he established improved methods for immune cell characterization including protocols for multi-parameter analysis of T cell, NK cell, and dendritic cell subsets and activation in the spleen, regional lymph nodes, mucosa, and within solid tumors. He is currently a Staff Scientist III at Children’s National Medical Center (CNMC) where he manages the operations of the Flow Cytometry Core and works within the Immune Testing and Characterization Lab as part of the Children’s Cell Therapy GMP facility.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.
Shop Sartorius Products Now